Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Some unanswered questions about the pyrimidine catabolic pathway: The human macrophage perspective. | Biochim Biophys Acta Rev Cancer | 2025 | 40158668 | PubTator, text mining | PubMed |
| Integrating network pharmacology and experimental validation to uncover the synergistic effects of Huangqi ()-Ezhu () with 5-fluorouracil in colorectal cancer models. | J Tradit Chin Med | 2025 | 40151125 | PubTator, text mining | PubMed |
| Pharmacogenomics in Solid Tumors: A Comprehensive Review of Genetic Variability and Its Clinical Implications. | Cancers (Basel) | 2025 | 40149251 | PubTator, text mining | PubMed |
| A Transcriptome-Wide Mendelian Randomization Study in Isolated Human Immune Cells Highlights Risk Genes Involved in Viral Infections and Potential Drug Repurposing Opportunities for Schizophrenia. | Am J Med Genet B Neuropsychiatr Genet | 2025 | 40126059 | PubTator, text mining | PubMed |
Adjuvant treatment with Capecitabine in patients who received orthotopic liver transplantation with incidental diagnosis of intrahepatic cholangiocarcinoma. Implications on DPYD polymorphisms assessment: report of two cases and review of the literature. | Cancer Chemother Pharmacol | 2025 | 40072607 | PubTator, text mining | PubMed |
| Unravelling the implementation of pharmacogenetic testing in Belgium. | Eur J Clin Pharmacol | 2025 | 40019504 | PubTator, text mining | PubMed |
| Computational framework for minimizing off-target toxicity in capecitabine treatment using natural compounds. | Mol Divers | 2025 | 40009148 | PubTator, text mining | PubMed |
| Impact of Upfront DPYD Genotyping on Fluoropyrimidine Adjuvant Therapy in Colorectal Cancer: A Real-World Data. | Clin Colorectal Cancer | 2025 | 40000255 | PubTator, text mining | PubMed |
| Abstracts of the 2024 Canadian Association of Medical Oncologists Annual Scientific Meeting. | Curr Oncol | 2025 | 39996905 | PubTator, text mining | PubMed |
| Feasibility and population exposure of 5-fluorouracil using therapeutic drug monitoring (PREDICT-5FU): A multicentre clinical trial. | Br J Clin Pharmacol | 2025 | 39988750 | PubTator, text mining | PubMed |
| Genetic and Functional Characterization of DPYD Exon 4 Deletion Common in the Finnish Population. | Basic Clin Pharmacol Toxicol | 2025 | 39988348 | PubTator, text mining | PubMed |
| Severe fluoropyrimidine toxicity in older adults with cancer with DPYD wild type. | Fundam Clin Pharmacol | 2025 | 39969252 | PubTator, text mining | PubMed |
| Thymine as potential biomarker to predict 5-FU systemic exposure in patients with gastro-intestinal cancer: a prospective pharmacokinetic study (FUUT-trial). | Cancer Chemother Pharmacol | 2025 | 39955449 | PubTator, text mining | PubMed |
| Case report: Chemotherapy plus sintilimab for the treatment of gastroesophageal junction hepatoid adenocarcinoma with liver metastasis: a case study with literature review. | Front Immunol | 2025 | 39931054 | PubTator, text mining | PubMed |
| A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical Practice. | Clin Pharmacol Ther | 2025 | 39887719 | PubTator, text mining | PubMed |
| Novel predictive biomarkers for atonic postpartum hemorrhage as explored by proteomics and metabolomics. | BMC Pregnancy Childbirth | 2025 | 39885444 | PubTator, text mining | PubMed |
| Dihydropyrimidine Dehydrogenase Deficiency (DPYD) Genotyping-Guided Fluoropyrimidine-Based Adjuvant Chemotherapy for Breast Cancer. A Cost-Effectiveness Analysis. | Clin Drug Investig | 2025 | 39885055 | PubTator, text mining | PubMed |
| A case report of hyperammonemic encephalopathy induced by high-dose continuous infusion of 5-fluorouracil in a patient with rectal cancer. | AME Case Rep | 2025 | 39866265 | PubTator, text mining | PubMed |
| Beyond chemotherapy: Exploring 5-FU resistance and stemness in colorectal cancer. | Eur J Pharmacol | 2025 | 39863147 | PubTator, text mining | PubMed |
| Pharmacogenetic Testing in Admixed Populations: Frequency of the Association for Molecular Pathology Pharmacogenomics Working Group Tier 1 Variant Alleles in Brazilians. | J Mol Diagn | 2025 | 39863018 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=10